Follow
Talia Velasco-Hernandez
Talia Velasco-Hernandez
Assistant professor Serra Hunter. Universidad de Barcelona
Verified email at ub.edu
Title
Cited by
Cited by
Year
Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells
D Li, ND Marchenko, R Schulz, V Fischer, T Velasco-Hernandez, F Talos, ...
Molecular Cancer Research 9 (5), 577-588, 2011
3392011
Metabolic and innate immune cues merge into a specific inflammatory response via the UPR
DA Mogilenko, JT Haas, L L’homme, S Fleury, S Quemener, ...
Cell 177 (5), 1201-1216. e19, 2019
1502019
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ...
Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019
1222019
HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia
T Velasco-Hernandez, A Hyrenius-Wittsten, M Rehn, D Bryder, ...
Blood, The Journal of the American Society of Hematology 124 (24), 3597-3607, 2014
1162014
Potential pitfalls of the Mx1-Cre system: implications for experimental modeling of normal and malignant hematopoiesis
T Velasco-Hernandez, P Säwén, D Bryder, J Cammenga
Stem cell reports 7 (1), 11-18, 2016
842016
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo
ML Baroni, DS Martinez, FG Aguera, HR Ho, M Castella, SR Zanetti, ...
Journal for immunotherapy of cancer 8 (1), 2020
562020
Hyaluronic acid–GPRC5C signalling promotes dormancy in haematopoietic stem cells
YW Zhang, J Mess, N Aizarani, P Mishra, C Johnson, MC Romero-Mulero, ...
Nature cell biology 24 (7), 1038-1048, 2022
522022
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
M Eriksson, P Peña-Martínez, R Ramakrishnan, M Chapellier, C Högberg, ...
Blood advances 1 (23), 2046-2057, 2017
462017
CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
C Bueno, T Velasco-Hernandez, F Gutiérrez-Agüera, SR Zanetti, ...
Leukemia 33 (8), 2090-2125, 2019
452019
A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL
SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera, VM Díaz, ...
Molecular Therapy 30 (2), 550-563, 2022
342022
Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts
M del Rey, R Benito, C Fontanillo, FJ Campos-Laborie, K Janusz, ...
PLoS One 10 (5), e0126555, 2015
322015
p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice
T Velasco-Hernández, C Vicente-Dueñas, I Sánchez-García, ...
Cell Cycle 12 (1), 122-132, 2013
242013
Hif-1Α deletion may lead to adverse treatment effect in a mouse model of Mll-Af9-driven aml
T Velasco-Hernandez, S Soneji, I Hidalgo, E Erlandsson, J Cammenga, ...
Stem cell reports 12 (1), 112-121, 2019
232019
Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia
T Velasco-Hernandez, D Tornero, J Cammenga
Leukemia 29 (12), 2366-2374, 2015
222015
Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice
MA Galindo-Campos, N Lutfi, S Bonnin, C Martínez, ...
Blood, The Journal of the American Society of Hematology 139 (2), 228-239, 2022
212022
Opportunities for CAR-T cell immunotherapy in HIV cure
G Campos-Gonzalez, J Martinez-Picado, T Velasco-Hernandez, ...
Viruses 15 (3), 789, 2023
162023
The “Never-Ending” mouse models for MLL-rearranged acute leukemia are still teaching Us
K Ottersbach, A Sanjuan-Pla, R Torres-Ruíz, C Bueno, ...
HemaSphere 2 (4), e57, 2018
152018
Engraftment characterization of risk-stratified AML in NSGS mice
R Díaz de la Guardia, T Velasco-Hernandez, F Gutiérrez-Agüera, ...
Blood advances 5 (23), 4842-4854, 2021
122021
Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope
T Velasco-Hernandez, SR Zanetti, H Roca-Ho, F Gutierrez-Aguera, ...
Journal for immunotherapy of cancer 8 (2), 2020
122020
Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia
P Jaako, A Ugale, M Wahlestedt, T Velasco-Hernandez, J Cammenga, ...
Leukemia 31 (1), 213-221, 2017
92017
The system can't perform the operation now. Try again later.
Articles 1–20